This week’s roundup of health care innovation news covers topics ranging from genetically modified babies to the thought that innovation can mean more than shiny new technology. Read on for more.
Often, we equate innovation with invention and things that are shiny and new. Author David Sax argues that’s not always the case. True innovation, he writes in an opinion piece in The New York Times, “is a continuing process of gradual improvement and assessment that every institution and business experiences in some way.” Innovation could mean taking an old idea and making it new again.
A Harvard Business Review article posits that a groundbreaking idea may not seem that way at first. Creative thinkers may hold back from acting on ideas because they seem too obvious of a solution. “‘Obvious’ answers aren’t obvious to most people, partly because most people aren’t thinking about the question,” the piece notes.
Some news from across the pond: England’s National Health Service plans to phase out fax machines by March 31, 2020. The Department of Health said secure email should replace the technology. Get more from BBC News.
Politico convened a panel of health care leaders to discuss areas in the industry they see as undergoing rapid change. Their picks included telemedicine, artificial intelligence and consumerism. Politico also gives policy takeaways for each.
In November, a scientist in China announced he created the world’s first genetically modified babies. He used CRISPR technology to edit the DNA of two embryos with the stated goal of making them immune to HIV infection. But his experiment spurred intense controversy. Various experts quoted in the news media have called it “appalling,” “abhorrent” and “largely useless.” Here’s the take from STAT News.